$VSTS

Vestis Corp (VSTS): Results of Operations and Financial Condition

Vestis Corp (VSTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 vstsq3fy26earningsrelease-.htm EX-99.1 Document Vestis Reports Third Quarter 2026 Results and Increases Full Year 2026 Outlook Increases full year 2026 Free Cash Flow* outlook by $30 million, or 22%, at the midpoint; On track to deliver against full year 2026 revenue an

Original reporting
Published Aug 11, 2026, 11:04 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 11:33 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$VSTS
Bullish
medium confidence
Mentioned
$VSTS
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$VSTSBullishMed
01

Why it matters

The filing provides quantified Q3 performance (revenue, net income, Adjusted EBITDA, cash flow) and a specific full-year 2026 free cash flow outlook increase, plus operational and commercial KPIs (plant productivity, on-time delivery, complaints, revenue per pound).

02

Market read

Traders can update near-term expectations for profitability and cash generation based on the raised full-year FCF midpoint and improved Adjusted EBITDA margin.

03

What to watch

The plan includes outsourcing SG&A savings beginning in fiscal 2027; investors may discount near-term benefits if execution risk or transition costs emerge, despite current progress.

Relevance 7/10Novelty 8/10Timing: filed pre-market today (Aug 11, 2026) with Q3 results and updated full-year outlook

Background

The 8-K (Item 2.02) reports Vestis’ fiscal third quarter ended July 3, 2026 and details progress on a 2026 strategic transformation plan targeting cost savings and improved commercial execution.

Company-level read

Ticker impact

$VSTSBullishMedium confidence
Context

Vestis reported fiscal Q3 results and raised full-year 2026 free cash flow outlook by $30 million at the midpoint, citing transformation execution.

Expected impact

Likely positive bias for the next trading session as the raised FCF outlook and higher Adjusted EBITDA margin can re-rate expectations.

Evidence & confidence

The filing includes multiple quantified improvements (Adjusted EBITDA margin 12.2% vs 9.5% prior year, operating cash flow $64.9M, FCF $47.0M) plus a specific outlook increase for full-year 2026 FCF, which is actionable for valuation and forward estimates.

Market effects

Signals improving operating leverage and pricing discipline in uniform/workplace supplies, potentially supportive for peers’ margin expectations.

No specific regional demand shock disclosed; impact is company-specific execution.

Limited global spillover; primarily a US-listed issuer earnings and outlook update.

Counterpoint

FCF outlook increase may be partially driven by working-capital timing and non-GAAP adjustments, so equity reaction could fade if investors focus on revenue softness (revenue down 1.8% YoY).

Key entities

  • Vestis Corporation

    NYSE-listed uniform and workplace supplies provider reporting Q3 results and raising full-year 2026 free cash flow outlook.

  • Jim Barber

    President and CEO quoted on operational and commercial progress and capital allocation priorities.

Related articles

$VSTSMed

Vestis Reports Net Income In Q3

Vestis (VSTS) reported Q3 net income of $11.0 million, or $0.08 per share, versus a year-ago net loss of $0.7 million, or $0.01 per share. Revenue fell to $661.7 million from $673.8 million. Adjusted EBITDA rose to $80.9 million from $64.0 million. For FY2026, it expects revenue flat to down 2% and adjusted EBITDA of $310.0 million to $315.0 million.

$ACCSMed

ACCESS Newswire Inc. (ACCS): Results of Operations and Financial Condition

ACCESS Newswire Inc. (ACCS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 access_ex9901.htm PRESS RELEASE Exhibit 99.1 ACCESS Newswire Reports Second Quarter 2026 Results Average ARR and cashflow from operations continue to increase over PY, as Adjusted EBITDA remains positive · Average ARR for subscriptions per customer at the end of Q2 2026

$ASTSMedAI 8/10

AST SpaceMobile Q2 2026 earnings miss, full-year guidance held

AST SpaceMobile reported Q2 2026 revenue of $31.5 million, below the $34.5 million analyst consensus cited by The Wall Street Journal, and reaffirmed full-year revenue guidance of $150 million to $200 million. Net loss attributable to common stockholders was $230.9 million, or 77 cents/share. Operating expenses rose to $329.1 million. Cash was about $2.7 billion.

$PFEMedAI 8/10

Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?

Pfizer (PFE) and BioNTech (BNTX) reported Q2 2026 results and updates after the European Commission authorized their updated XFG-adapted COVID-19 vaccine on July 29. Pfizer posted Q2 revenue of $15.0B, Adjusted EPS $0.77, and raised full-year revenue guidance to $60.5–$62.5B. BioNTech’s Q2 revenue fell 59.5% to €105.6M and net loss widened to €820.8M, with guidance cut to €1.6–€1.9B.

$ACCSMed

ACCESS Newswire Inc.: ACCESS Newswire Reports Second Quarter 2026 Results

ACCESS Newswire Inc. (NYSE American:ACCS) reported Q2 2026 results: revenue rose to $5.6M from $5.3M in Q1 2026 and matched Q2 2025. Gross margin fell to 73% from 76% in Q2 2025. Adjusted EBITDA was $642k versus $836k a year earlier. Average ARR per subscription customer increased to $12,718. The company also reported a Q2 operating loss of $0.3M and cash flow from operations of $173k.